Vassiliki Poulaki - Concepedia

Author

Vassiliki Poulaki

Massachusetts Eye and Ear Infirmary

Also Known As

V Poulaki, Vassiliki Poulaki

Publications

9.9K

Citations

H-Index

Concepts

All Affiliations

Massachusetts Eye and Ear Infirmary Harvard University Dana-Farber Cancer Institute University of Cologne National and Kapodistrian University of Athens

About

Vassiliki Poulaki is an author at Massachusetts Eye and Ear Infirmary specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	5.5K
2	Cell Biology	17	19	4.5K
3	Diabetes	8	8	2.9K
4	Health Sciences	3	3	240
5	Cellular Physiology	1	1	45

Vassiliki Poulaki

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
A central role for inflammation in the pathogenesis of diabetic retinopathy Antonia M. Joussen, Vassiliki Poulaki, Minh Ly Le, The FASEB Journal InflammationDiabetic RetinopathyCentral RoleRetinaOcular Disease	2004	1.2K
Molecular sequelae of proteasome inhibition in human multiple myeloma cells Nicholas Mitsiades, Constantine Mitsiades, Vassiliki Poulaki, Proceedings of the National Academy of Sciences	2002	747
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications Nicholas Mitsiades, Constantine S. Mitsiades, Paul G. Richardson, Blood	2003	701
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki, Blood	2002	666
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan, Cancer Cell Hematological MalignancySolid TumorsMedicineReceptor Tyrosine KinaseImmunology	2004	610
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression Antonia M. Joussen, Vassiliki Poulaki, Nicholas Mitsiades, The FASEB Journal InflammationDiabetic RetinopathyOcular DiseaseWhereas MeloxicamAnti-inflammatory	2002	565
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications Constantine S. Mitsiades, Nicholas Mitsiades, Ciaran J. McMullan, Proceedings of the National Academy of Sciences Histone ModificationsHistone DeacetylasesEpigenetic ChangeApoptosisCell Death	2003	527
Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications Constantine S. Mitsiades, Nicholas Mitsiades, Vassiliki Poulaki, Oncogene InflammationCancer ResearchIgf-1/akt SignalingMedicineImmunology	2002	460
Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in Vivo Antonia M. Joussen, Vassiliki Poulaki, Wenying Qin, American Journal Of Pathology Diabetic RetinopathyOcular DiseaseRetinaOphthalmologyDiabetes	2002	389
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki, Blood	2002	367

Page 1